Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
The blood–brain barrier (BBB) is often a limiting factor for getting drugs in the brain. Bypassing the BBB by intranasal (IN), or also called nose to brain (NTB), route is an interesting and frequently investigated concept for brain drug delivery. However, despite the body of evidence for IN drug de...
Main Authors: | Deborah Dhuyvetter, Fetene Tekle, Maxim Nazarov, Rob J. Vreeken, Herman Borghys, Frederik Rombouts, Ilse Lenaerts, Astrid Bottelbergs |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2020.1837291 |
Similar Items
-
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
by: Shiv Bahadur, et al.
Published: (2020-12-01) -
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
by: Teresa Musumeci, et al.
Published: (2019-03-01) -
Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation
by: Hosny KM
Published: (2020-07-01) -
Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases
by: Roberta Cassano, et al.
Published: (2021-04-01) -
Aerosolized In Vivo 3D Localization of Nose-to-Brain Nanocarrier Delivery Using Multimodality Neuroimaging in a Rat Model—Protocol Development
by: Michael C. Veronesi, et al.
Published: (2021-03-01)